Abstract

A COMPARATIVE STUDY OF REGULATORY REQUIREMENTS FOR DIETARY SUPPLEMENTS IN INDIA, THE UNITED STATES, AND THE EUROPEAN UNION

*Vaishnavi Kamlesh Acharya, Mr. Shoaib Ali

Abstract

The global dietary supplement industry has witnessed unprecedented growth over the past decade, driven by rising consumer awareness of preventive healthcare, an ageing population, and the increasing popularity of self-care and wellness products. However, dietary supplements occupy a unique and often ambiguous regulatory space – positioned between conventional foods and pharmaceutical drugs – and the regulatory frameworks governing their safety, quality, labelling and marketing differ markedly across jurisdictions. This dissertation presents a comparative analysis of the regulatory requirements for dietary supplements (encompassing health supplements, nutraceuticals and food supplements) in three major regulatory regions: India, the United States, and the European Union. The study examines the legal definitions, classification systems, regulatory authorities, pre-market approval or notification pathways, permitted ingredients and dosage limits, Good Manufacturing Practice (GMP) requirements, labelling obligations, health claim substantiation frameworks, post-market surveillance mechanisms, adverse event reporting systems, and enforcement and penalty structures applicable in each jurisdiction. The Indian framework is examined under the Food Safety and Standards Authority of India (FSSAI) and the Food Safety and Standards Act, 2006, together with the Health Supplements, Nutraceuticals, Food for Special Dietary Use, Food for Special Medical Purpose, Prebiotic and Probiotic Food Regulations. The United States framework is examined under the Dietary Supplement Health and Education Act of 1994 (DSHEA), the Food and Drug Administration (USFDA) and 21 CFR Part 111. The European Union framework is examined under Directive 2002/46/EC on Food Supplements, Regulation (EC) No. 1924/2006 on Nutrition and Health Claims, Regulation (EU) 2015/2283 on Novel Foods, and the role of the European Food Safety Authority (EFSA). A descriptive, doctrinal and comparative research methodology was adopted, relying on primary legal texts, regulatory guidance documents, official notifications and authoritative secondary literature. The findings reveal that while all three jurisdictions share the common objective of ensuring consumer safety, significant divergence exists in regulatory philosophy: India and the European Union largely regulate dietary/health supplements as a category of food requiring licensing or notification, whereas the United States treats dietary supplements as a distinct category under food law with minimal pre-market intervention but strict post-market accountability. The comparative analysis further highlights differences in permitted ingredient lists, maximum dosage limits, the rigour of health claim substantiation, and the stringency of adverse event reporting obligations. The dissertation concludes that regulatory divergence among these three major markets continues to act as a significant barrier to international trade and harmonisation, and that India's regulatory framework, although rapidly evolving, would benefit from a more clearly codified ingredient safety assessment pathway, a centralised adverse event reporting system analogous to the US MedWatch/CAERS system, and a positive list of pre-approved health claims similar to the EU model. The study offers practical recommendations for regulatory professionals, manufacturers and policy makers engaged in the global dietary supplement trade, and identifies areas for future research, including the regulatory treatment of novel ingredients, digital/online sale of supplements, and progress toward international harmonisation under Codex Alimentarius guidelines.

Keywords: Dietary Supplements, Health Supplements, Nutraceuticals, FSSAI, USFDA, DSHEA, European Food Safety Authority (EFSA), Regulatory Affairs, Comparative Regulatory Analysis, Food Supplement Directive, Novel Food, Health Claims, Good Manufacturing Practices.